Selling Skye Bioscience Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders
Even though Skye Bioscience, Inc. (NASDAQ:SKYE) has fallen by 16% over the past week , insiders who sold US$1.2m worth of stock over the past year have had less luck. Insiders might have been better off holding onto their shares, given that the average selling price of US$4.99 is still below the current share price.
While insider transactions are not the most important thing when it comes to long-term investing, we would consider it foolish to ignore insider transactions altogether.
The Last 12 Months Of Insider Transactions At Skye Bioscience
In the last twelve months, the biggest single sale by an insider was…
